Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Palliative cancer care - dyspnoea - Drugs in this topic
Scenario: Symptomatic treatment

This level contains the following sections:

  • AeroChamber Plus
  • Airomir 100micrograms/dose inhaler
  • Diazepam 2mg tablets
  • Diazepam 5mg tablets
  • Ipratropium bromide 20micrograms/dose inhaler
  • Ipratropium bromide 250micrograms/1ml nebuliser liquid unit dose vials
  • Ipratropium bromide 500micrograms/2ml nebuliser liquid unit dose vials
  • Lorazepam 1mg tablets
  • Midazolam 10mg/2ml solution for injection ampoules
  • Morphine sulphate 10mg/5ml oral solution
  • Salbutamol 100micrograms/dose inhaler CFC free
  • Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials
  • Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials
  • Terbutaline 5mg/2ml nebuliser liquid unit dose vials
  • Ventolin 100micrograms/dose Evohaler
  • Volumatic

© NHS Institute for Innovation and Improvement